Research Months


Last updated 2023-03-02

The Swedish Cancer Society, organization number 802005-3370, 101 55 Stockholm, is the body responsible for the collection and processing of personal data in connection with grant applications.  

Changes to the call for Research Months

The Swedish Cancer Society has decided to move the call for Research Months from the spring round to the autumn round as of 2023.

We will have two calls in 2023, one in the spring as usual and one in the autumn. From 2024 onwards, the call will only take place in the autumn.

Applicants whose grants expire in 2023-12-31 need to apply in spring 2023 as usual.

Applicants whose grants expire on 2024-12-31 will need to apply in autumn 2023, etc.

From autumn 2023 onwards, grants will start on 1 July each year instead of 1 January. This means that some of you will have double grants for six months. We will give you the opportunity to extend your disposition time if needed.

Information will be available on our website in the future. If you have any questions please contact

Information regarding the Fenix grant application system  

The Swedish Cancer Society has a digital grant application system called Fenix. Fenix uses BankID and Swedish social security numbers for both identification and signing.

The application is signed digitally by both the Head of Department and the applicant directly in Fenix. Applicants sign the application last, i.e. after the Head of Department has signed.   

Note that if you make changes to the application after sending it to the Head of Department for signing, you must send a new request for signing by your Head of Department, as the application has changed. This applies regardless of what changes have been made.  

The signing deadline for applicants in Fenix is 2nd May 2023, at 3pm.    


Grants for Research Months are intended to provide the opportunity for cancer researchers with clinical positions within the medical, healthcare, social and behavioral science professions to set aside time for research.

After the allocation of Research Months, the remaining clinical activities shall amount to at least 50% of full-time employment at a Swedish healthcare facility or equivalent.

Applications are welcomed from researchers in many different fields such as medicine, healthcare, natural sciences, technology, social sciences, public health sciences, behavioral and communication sciences.  

The aims and rationale for what will be achieved during the research period and the applicant's role in the project must be clearly stated in the application.  

The grant is to cover the researcher's salary during the grant period.        


The Swedish Cancer Society pays research grants only to Swedish educational institutions.

Research Months can be applied for by clinically active doctoral researchers with documented research experience.  

Professors or lecturers with university positions are not eligible for Research Months for clinically active persons.  

Grant period  

Research Months is a grant towards the researcher's salary for one to three months per year. Applications can be made for a maximum of three years at a time.

The grant period is usually January 1 - December 31, and the period of performance is the same as the grant period.        

Size of grants  

Grants in the Research Months category are standardized. The current standard is, which includes holiday allowances and salary costs. The grant also includes supplements for indirect costs.

The actual salary of the grant holder is determined by the employer.

See current salary scales

Administrative authority  

The Swedish Cancer Society allows deductions for indirect costs up to a maximum of 15.25 percent of the grant.

When signing and confirming the application, the Head of Department guarantees co-financing of the project if the above deductions prove to be insufficient.  

Basis of assessment  


Qualifications must be included in the Fenix application. You need to fill in your qualifications in every application you want to apply for.    

Research program  

The research program may comprise a maximum of ten pages including references (12pt, single line spacing, 2.5 cm margin).  

The research program may be written in English.  

The following outline is recommended for the research program:

  • Specific objectives
    A brief account of the aim of the proposed research work.
  • Background
    Summary of your own and others' results in the research area.
  • Work plan and preliminary results
    Detailed description of hypotheses and planned work. The work plan should also include a methodological description where it is made clear that current technology/methodology, including statistical considerations, power analysis, etc., is in place and mastered, or is otherwise available for the project in question. Preliminary results are of great importance when applying for grants for new projects.
  • Significance
    Brief account of the expected importance for cancer research.
  • Litteratur references
    Author, title of work, publication name, volume, page, year of publication. Include only the essential references.  

Applicant's role

Describe the applicant's role in the project in detail, for example:

  • Is the applicant considered to be the principal of the project?
  • Is the applicant considered important for networks within or between projects?
  • Is the applicant at an early stage of the project important for building collaborative structures?    

Cancer relevance  

According to the Swedish Cancer Society's statutes, the society shall "support, organize and coordinate cancer research ...".

In the application form there is a special field where the applicant must explain and justify the cancer relevance.

Patient perspective

Many of the projects supported by the Swedish Cancer Society either take advantage of patients' experiences, or lead to knowledge that can affect patients. If your project belongs to this category, you need to indicate whether the patient perspective has been taken into account and, if so, in what way. There is a specially designated box for such a description in the application under the heading “patient perspective”.

Examples could be that patients have been involved in the planning of a clinical study, that there has been a discussion with patients in the development of the research program, that the research project is based on patient contacts, or that the project has otherwise considered the family/patient perspective in its design. There are co-opted patients sitting on some of the Swedish Cancer Society's priority committees.

If you consider that the patient perspective is not relevant to your project or the development of your research program, you should justify this in this box instead.

Popular scientific description  

This text will be published on if your grant is approved and can be read by people who donate to the Cancer Foundation, who have been affected by cancer, are relatives and others interested.

Therefore, feel free to write simply and concisely. The text must be in Swedish and a maximum of 650 characters per question / section. Your text will not be edited but will be published as you type it.   

  1. Write a title that is easy to understand.   
  2. What is the background of the project?   
  3. What is the project about? Describe, for example, which cancer diseases are being studied, what treatment it is about, whether it is in diagnostics, epidemiology, prevention or care of cancer patients, or whether it is about how cancer arises.   
  4. What do you hope to achieve with your research?   
  5. Write a brief summary of the project for those who want to know quickly what it is about.  

Scientific progress

The experts in the committées must be able to assess the progress of the project during the most recent grant period.

  1. Provide a brief description of important results from the last grant period.
  2. List the scientific works (printed or in manuscript form) funded by the last grant received. Abstracts should not be included in the report.

References must be complete including title and all authors. The list of authors should be consistent with the one used in PubMed. Patents obtained during the grant period must be listed.

Work related to projects not funded by the Swedish Cancer Society should not be included in the report.

Practical guidelines  

Funding from other financing organizations  

Holders of grants or assignments from the tobacco industry may not at the same time receive funding from the Swedish Cancer Society.


Applications are made in the Swedish Cancer Society's new grant application system Fenix. Applications can be saved and altered until you have pressed the button "Request signing/Be om signering".

Applications cannot be signed and submitted unless all the tabs in the application form are marked in green.  

Applications cannot be altered or supplemented after the end of the application period.

Pdf appendices   

  • Page Merits (in Fenix): 10 selected original articles, not reviews book chapters etc.
  • Page Merits (in Fenix): Not yet published manuscripts with original data max 3.(Attached as pdf)
  • Page Merits (in Fenix): Full publication list. (Attached as pdf)
  • Page Projext Info (in Fenix):  Research program, max 10 pages. (Attached as pdf)
  • If renewal of grant Page Scientific Report (in Fenix): List of publications, only in case the alotted space is too small. (Attached as pdf)    

Signing the application  

When you have completed your application, you must send it to your Head of Department by going into the "Preview/Förhandsgranska" tab.

At the bottom of the page you click on "Request signing/Be om signering". This sends the application to your Head of Department, who receives it and signs it digitally with BankID.  

Note that if you make changes to the application after sending it to the Head of Department for signing, you must send a new request for signing by your Head of Department, as the application has changed. This applies regardless of what changes have been made.  

When the Head of Department has signed the application digitally with BankID, you as the applicant will receive an email and can then log in and in turn sign the application digitally with BankID.  

Application signing period  

The deadline for signing the application is 2nd May 2023 at 3pm.  


Decisions will be made at the meeting of the Research Committee in November 2023.

Decisions and written feedback reports will be available in Fenix two weeks after the meeting.  


Change of address  

The principal applicant is responsible for ensuring that up-to-date personal and institution contact information is entered into the Fenix application portal.  

Change of administrative authority / department  

When transferring grants to another administrative authority or to another department within the current university or high school, the application for transfer must be made in Fenix with digital signing / approval from both the current and receiving Heads of Department.

Reports (financial and scientific)  

Not later than three months (see contract) after the end of the period of performance, a report must be submitted via Fenix.

Unused funds must be repaid.


Contact the Research department at telephone number 010 - 199 10 10, or by email

Use of personal data

Read more about the Swedish Cancer Society's handling of personal data in the Swedish Cancer Society's privacy policy (in Swedish).

Vill du få information om vårt arbete för att besegra cancer?


Genom att gå vidare samtycker jag till att mina personuppgifter behandlas i enlighet med Cancerfondens integritetspolicy.